New stock news | Zhongan Xinke plans to list in Hong Kong. China Securities Regulatory Commission requires supplementary explanation on the pricing basis for each capital increase and equity transfer.

The China Securities Regulatory Commission issued the "Supplementary materials requirements for overseas issuance and listing filing (March 16, 2026 - March 20, 2026)". The CSRC's International Department has issued supplementary material requirements for 8 companies, including a request for Zhongan Xinke to provide further explanations on the pricing basis for each capital increase and equity transfer. It is reported that Zhongan Xinke has submitted an IPO application to the Main Board of the Hong Kong Stock Exchange on January 5, 2026, with ICBC International and Guolian Securities International as joint sponsors. The CSRC has requested Zhongan Xinke to provide explanations on the following matters and to have lawyers verify and provide clear legal opinions: 1. Regarding changes in equity: (1) Please explain the basis for each capital increase and equity transfer, whether the capital has been actually paid, whether there are situations of unfulfilled capital obligations, capital extraction, or defects in the capital contribution method, and provide a clear conclusion on the legality and compliance of each equity change; (2) Please explain whether there are entities with a shareholding of more than 5% that are prohibited from holding shares after upward penetration; (3) Conduct a verification of the historical equity proxy holding of the company in accordance with the requirements of the "Regulatory Rules Application Guidelines - Overseas Issuance and Listing No. 2". 2. Conduct a verification of the employees' shareholding plans and equity incentive plans in the company's historical development in accordance with the requirements of the "Regulatory Rules Application Guidelines - Overseas Issuance and Listing No. 2". 3. Strictly compare with the provisions of Article 8 of the "Measures for the Administration of Overseas Issuance of Securities and Listing by Domestic Enterprises", and explain whether the company and its domestic subsidiaries have any prohibitive circumstances for overseas issuance and listing, and have lawyers verify and provide clear legal opinions. 4. Regarding the current issuance and listing and "full circulation": (1) Please explain the specific arrangements for the company's stock split, whether it will affect the number of shares issued in this offering; (2) Please explain the expected amount of funds to be raised after fully exercising the over-allotment option; (3) Please explain whether there are any situations of pledged shares, frozen shares, or other defects in rights of the shareholders participating in the "full circulation" in this offering. According to the prospectus, Zhongan Xinke is an enterprise-level AI solutions provider, focusing on intelligent marketing and intelligent operations management solutions. Zhongan Xinke provides intelligent marketing and intelligent operations management solutions to help clients accelerate AI deployment, improve operational and marketing efficiency, expand business scale, and strengthen competitiveness. Through the combination of advanced technologies, including large-scale model-driven application capabilities, knowledge engineering and AI intelligent scheduling, as well as deep industry insights and business knowledge, the company provides solutions that are both technically sophisticated and operationally efficient, helping clients achieve sustainable and scalable AI transformation. The number of clients served by Zhongan Xinke has increased from 88 as of December 31, 2023, to 241 as of December 31, 2024, and further expanded to 338 as of September 30, 2025, with a compound annual growth rate of 63.1%.